HOME
About Us
Company Overview
Our Technologies
Our Team
Careers
What We Do
Process Development
GMP Manufacturing
Fill & Finish
QA & QC
Resources
News Archive
Events
Articles/Publications
CN
|
EN
Contact Us
×
CN
|
EN
HOME
About Us
Company Overview
Our Technologies
Our Team
Careers
What We Do
Process Development
GMP Manufacturing
Fill & Finish
QA & QC
Resources
News Archive
Events
Articles/Publications
Contact Us
Articles/Publications
HIV-1 DNA Flap formation promotes uncoating of the pre-integration complex at the nuclear pore
The HIV‐1 central DNA Flap acts as a cis‐acting determinant of HIV‐1 genome nuclear import. Indeed, DNA‐Flap re‐insertion within lentiviral‐derived gene transfer vectors strongly stimulates gene transfer efficiencies. In this study, we sought to understand the mechanisms by which the central DNA Flap mediates HIV‐1 nuclear import. Here, we s...
Protective antiviral immunity conferred by a nonintegrative lentiviral vector-based vaccine
Lentiviral vectors are under intense scrutiny as unique candidate viral vector vaccines against tumor and aggressive pathogens because of their ability to initiate potent and durable specific immune responses. Strategies that alleviate safety concerns will facilitate the clinical developments involving lentiviral vectors. In this respect, the devel...
Lentiviral vector-based prime/boost vaccination against AIDS: pilot study shows protection against Simian immunodeficiency virus SIVmac251 challenge in macaques
AIDS vaccination has a pressing need for more potent vaccination vectors capable of eliciting strong, diversified, and long-lasting cellular immune responses against human immunodeficiency virus (HIV). Lentiviral vectors have demonstrated efficiency not only as gene delivery vehicles for gene therapy applications but also as vaccination tools. This...
Immunogenicity of a recombinant lentiviral vector carrying human telomerase tumor antigen in HLA-B*0702 transgenic mice
Over expression of telomerase represents a hallmark of cancer cells and the induction of T cell immunity against this universal tumor antigen have gained promising interest for anticancer immunotherapy. In this study we evaluated a recombinant lentiviral vector expressing the human telomerase reverse transcriptase (lv-hTERT) vaccination in the huma...
Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experi mental autoimmune encephalomyelitis
Activated B cells can regulate immunity and have been envisaged as a potential cell-based therapy for treating autoimmune diseases. However, activated human B cells can also propagate immune responses, and the effects resulting from their infusion into patients cannot be predicted. This led us to consider resting B cells, which in contrast are poor...
home page
prev
1
2
3
next
Tail page